These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 7860926

  • 21. Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension.
    Thöne-Reineke C, Olivier J, Godes M, Zart R, George I, Bauer C, Neumayer HH, Hocher B.
    Clin Sci (Lond); 2003 Jan; 104(1):79-85. PubMed ID: 12519090
    [Abstract] [Full Text] [Related]

  • 22. Effects of diltiazem on down-regulation of lymphocyte beta-adrenoceptors in patients with chronic congestive heart failure.
    Zhang XL, Xu B, Feng Y.
    Acta Pharmacol Sin; 2000 Oct; 21(10):927-30. PubMed ID: 11501046
    [Abstract] [Full Text] [Related]

  • 23. Myocardial beta-adrenoceptors in pacing-induced heart failure: regulation by enalapril?
    Forster C, Naik GO, Larosa G.
    Can J Physiol Pharmacol; 1994 Jun; 72(6):667-72. PubMed ID: 7954098
    [Abstract] [Full Text] [Related]

  • 24. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
    Sanbe A, Takeo S.
    Circulation; 1995 Nov 01; 92(9):2666-75. PubMed ID: 7586371
    [Abstract] [Full Text] [Related]

  • 25. Effects of enalapril and L-158809 on myocardial beta-adrenergic receptor density in transplanted rat hearts.
    Nakame T, Iguchi A, Tabayashi K.
    Eur Surg Res; 2001 Nov 01; 33(4):297-302. PubMed ID: 11684837
    [Abstract] [Full Text] [Related]

  • 26. Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy.
    Makino N, Matsui H, Masutomo K, Hata T, Yanaga T.
    Mol Cell Biochem; 1993 Feb 17; 119(1-2):23-8. PubMed ID: 8384300
    [Abstract] [Full Text] [Related]

  • 27. Lack of effect of chronic calcium antagonist treatment on beta 1- and beta 2-adrenoceptors in right atria from patients with or without heart failure.
    Brodde OE, Hundhausen HJ, Zerkowski HR, Michel MC.
    Br J Clin Pharmacol; 1992 Mar 17; 33(3):269-74. PubMed ID: 1315561
    [Abstract] [Full Text] [Related]

  • 28. Decrease in beta 1- and increase in beta 2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation.
    Steinfath M, von der Leyen H, Hecht A, Neumann KH, Schmitz W, Scholz H, Haverich A, Heublein B.
    J Mol Cell Cardiol; 1992 Oct 17; 24(10):1189-98. PubMed ID: 1336061
    [Abstract] [Full Text] [Related]

  • 29. Beta adrenoceptor density in the donor heart: a guide to prognosis?
    Chester MR, Amadi AA, Barnett DB.
    Br Heart J; 1995 Jun 17; 73(6):540-3. PubMed ID: 7626353
    [Abstract] [Full Text] [Related]

  • 30. Diabetes-induced down-regulation of beta1-adrenoceptor mRNA expression in rat heart.
    Matsuda N, Hattori Y, Gando S, Akaishi Y, Kemmotsu O, Kanno M.
    Biochem Pharmacol; 1999 Sep 01; 58(5):881-5. PubMed ID: 10449200
    [Abstract] [Full Text] [Related]

  • 31. Beta-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of beta1-adrenoceptor density.
    Anthonio RL, Brodde OE, van Veldhuisen DJ, Scholtens E, Crijns HJ, van Gilst WH.
    Int J Cardiol; 2000 Jan 15; 72(2):137-41. PubMed ID: 10646955
    [Abstract] [Full Text] [Related]

  • 32. Differential down-regulation of pulmonary beta 1- and beta 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline.
    Nishikawa M, Mak JC, Shirasaki H, Barnes PJ.
    Eur J Pharmacol; 1993 Oct 15; 247(2):131-8. PubMed ID: 8282002
    [Abstract] [Full Text] [Related]

  • 33. Development of beta-adrenoceptor number and subtype distribution in the transplanted human heart.
    Zerkowski HR, Khamssi M, Brodde OE.
    Eur Heart J; 1991 Dec 15; 12 Suppl F():124-6. PubMed ID: 1666551
    [Abstract] [Full Text] [Related]

  • 34. Preventive effects of diltiazem on cyclosporin A-induced vascular smooth muscle dysfunction.
    Götze S, Auch-Schwelk W, Bossaller C, Thelen J, Fleck E.
    Transpl Int; 1994 May 15; 7(3):157-62. PubMed ID: 8060463
    [Abstract] [Full Text] [Related]

  • 35. Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes?
    Brodde OE, Michel MC, Gordon EP, Sandoval A, Gilbert EM, Bristow MR.
    Eur Heart J; 1989 Jun 15; 10 Suppl B():2-10. PubMed ID: 2553408
    [Abstract] [Full Text] [Related]

  • 36. Desipramine treatment differently down-regulates beta-adrenoceptors of freshly isolated neurons and astrocytes.
    Sapena R, Morin D, Zini R, Morin C, Tillement JP.
    Eur J Pharmacol; 1996 Apr 04; 300(1-2):159-62. PubMed ID: 8741184
    [Abstract] [Full Text] [Related]

  • 37. Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases.
    Steinfath M, Geertz B, Schmitz W, Scholz H, Haverich A, Breil I, Hanrath P, Reupcke C, Sigmund M, Lo HB.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb 04; 343(2):217-20. PubMed ID: 1648674
    [Abstract] [Full Text] [Related]

  • 38. Design of a desipramine dosing regimen for the rapid induction and maintenance of maximal cortical beta-adrenoceptor downregulation.
    Argenti D, D'Mello AP.
    Neuropharmacology; 1994 Sep 04; 33(9):1117-24. PubMed ID: 7838325
    [Abstract] [Full Text] [Related]

  • 39. Amiodarone has exclusively non-genomic action on cardiac beta-adrenoceptor regulation.
    Vassy R, Starzec A, Yin Y, Nicolas P, Perret GY.
    Eur J Pharmacol; 2000 Nov 24; 408(3):227-32. PubMed ID: 11090638
    [Abstract] [Full Text] [Related]

  • 40. [The calcium paradox in the isolated rat heart--effects of diltiazem].
    Ravingerová T, Ziegelhöffer A, Tribulová N, Slezák J, Trégerová V.
    Cesk Fysiol; 1989 Nov 24; 38(6):491-4. PubMed ID: 2630048
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.